English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Jaguar8 commented on a stock · Oct 29, 2024 21:16

NEWS

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology
FibroBiologics (Nasdaq: FBLG) reported promising results from its artificial thymus organoid program. The technology demonstrated that fibroblasts and thymus-derived cell organoids can maintain functionality for over 50 days after transplantation, showing vascularization and generating diverse mature T cells in animal models. The organoids produced fully mature T cells with various differentiation capabilities, including CD4, CD8, T-regulatory, and gamma delta T cells. The artificial thymus also generates T cells with diverse TCR-beta chains for broad antigen recognition, potentially supporting immune function in patients with immune dysregulation or post-chemotherapy conditions.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
5530 Views
Comment
Sign in to post a comment
    avatar
    Jaguar8
    Spread kindness and love. Life is short. Don’t let greed eat you.
    8155
    Followers
    50
    Following
    93K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartPrice
    TSLA
    Tesla
    -- 355.840
    NVDA
    NVIDIA
    -- 138.850
    INTC
    Intel
    -- 23.600
    NBIS
    NEBIUS
    -- 44.490
    PLTR
    Palantir
    -- 119.160
    Discussing
    Trump 2.0 Era: How will global markets evolve?
    🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
    MicroStrategy Q4 2024 earnings conference call
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.